Since our founding in 2007, we've put tenacity and innovation to work to develop unique therapeutics with the potential to set new standards of care.
Akebia Therapeutics is a fully integrated biopharmaceutical company focused on addressing complications of kidney disease, with two FDA-approved products.
Developer of an artificial intelligence-based financial platform designed to automate tasks and improve compliance. The company's platform offers a GPT-powered AI assistant that helps to identify risks and areas for improvement for financial advisors, enabling customers to automate tasks, boost efficiency, and meet regulatory requirements.